Your browser doesn't support javascript.
loading
Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy.
Mazor, Roei D; Weissman, Ran; Luckman, Judith; Domachevsky, Liran; Diamond, Eli L; Abdel-Wahab, Omar; Shapira, Shirley; Hershkovitz-Rokah, Oshrat; Groshar, David; Shpilberg, Ofer.
Afiliación
  • Mazor RD; Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel.
  • Weissman R; Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel.
  • Luckman J; Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel, Israel.
  • Domachevsky L; Translational Research Lab, Assuta Medical Centers, Tel-Aviv, Israel.
  • Diamond EL; Department of Imaging, Assuta Medical Center, Tel Aviv, Israel.
  • Abdel-Wahab O; Department of Imaging, Assuta Medical Center, Tel Aviv, Israel.
  • Shapira S; Department of Nuclear Medicine, Assuta Medical Center, Tel Aviv, Israel.
  • Hershkovitz-Rokah O; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Groshar D; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Shpilberg O; Institute of Hematology, Meir Hospital, Kfar Saba, Israel.
Neurooncol Adv ; 2(1): vdaa024, 2020.
Article en En | MEDLINE | ID: mdl-32642685
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2020 Tipo del documento: Article País de afiliación: Israel
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neurooncol Adv Año: 2020 Tipo del documento: Article País de afiliación: Israel